T Rinda Soong

No ORCID on file · 9 papers in corpus · active 2018-2025

Study types

  • preprint 4
  • other 2
  • review 2
  • article 1

Condition tags

  • endometriosis 8
article 2025
·doi:10.1158/0008-5472.30699610

Supplementary figures and table

preprint 2023
·doi:10.1158/0008-5472.c.6514212.v1

AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …

preprint 2023
·doi:10.1158/0008-5472.c.6514212

AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …

other 2023
JCI insight ·doi:10.1172/jci.insight.164995

Epigenetic aberrations, including posttranslational modifications of core histones, are major contributors to cancer. Here, we define the status of histone H2B monoubiquitylation (H2Bub1) in clear cell ovarian carcinoma (CCOC), low-grade se…

preprint 2023
·doi:10.1158/0008-5472.22432671.v1

Supplementary figures and table

preprint 2023
·doi:10.1158/0008-5472.22432671

Supplementary figures and table

other 2022
Cancer research ·doi:10.1158/0008-5472.CAN-22-1294

UNLABELLED: Ovarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem ce…

review 2018
Hematology/oncology clinics of North America ·doi:10.1016/j.hoc.2018.07.013
review 2018
Gynecologic oncology ·doi:10.1016/j.ygyno.2018.08.005

Given the current lack of effective screening for ovarian cancer, surgical removal of at-risk tissue is the most successful strategy to decrease risk of cancer development. However, the optimal timing of surgery and tissues to remove, as we…